A detailed history of Black Rock Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,432,315 shares of LNTH stock, worth $691 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,432,315
Previous 8,466,740 0.41%
Holding current value
$691 Million
Previous $525 Million 0.02%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$51.07 - $68.26 $1.76 Million - $2.35 Million
-34,425 Reduced 0.41%
8,432,315 $525 Million
Q4 2023

Feb 13, 2024

BUY
$55.6 - $77.89 $21.7 Million - $30.3 Million
389,581 Added 4.82%
8,466,740 $525 Million
Q3 2023

Nov 13, 2023

BUY
$60.27 - $90.75 $638,681 - $961,677
10,597 Added 0.13%
8,077,159 $561 Million
Q2 2023

Aug 11, 2023

BUY
$82.41 - $99.65 $21.3 Million - $25.8 Million
258,825 Added 3.31%
8,066,562 $677 Million
Q1 2023

May 12, 2023

SELL
$47.76 - $82.86 $18.9 Million - $32.8 Million
-395,734 Reduced 4.82%
7,807,737 $645 Million
Q4 2022

Feb 13, 2023

SELL
$48.76 - $77.67 $128 Million - $204 Million
-2,628,220 Reduced 24.26%
8,203,471 $418 Million
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $5.55 Million - $7.8 Million
90,399 Added 0.84%
10,831,691 $762 Million
Q2 2022

Aug 12, 2022

BUY
$55.54 - $72.65 $4.16 Million - $5.45 Million
74,974 Added 0.7%
10,741,292 $709 Million
Q1 2022

May 12, 2022

SELL
$24.28 - $56.64 $220,438 - $514,234
-9,079 Reduced 0.09%
10,666,318 $590 Million
Q4 2021

Feb 10, 2022

BUY
$22.54 - $30.44 $3.23 Million - $4.37 Million
143,451 Added 1.36%
10,675,397 $308 Million
Q3 2021

Nov 09, 2021

SELL
$24.23 - $28.59 $7.26 Million - $8.57 Million
-299,824 Reduced 2.77%
10,531,946 $270 Million
Q2 2021

Aug 11, 2021

BUY
$19.51 - $27.64 $211 Million - $299 Million
10,831,770 New
10,831,770 $299 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.63B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.